In patients who are event-free after 3-6 months of DAPT and who are not at high ischaemic risk, what change in antithrombotic therapy…

…the possibility of performing an electrophysiological study (EPS) for risk stratification. Regarding the use of EPS in asymptomatic Brugada syndrome (BrS) patients, which of the…

…The patient strongly denies any exertional dyspnea, angina, or syncope, and maintains an active lifestyle. He is inquiring about the potential benefits of pre-emptive…

…tolerated well for the past year. He is scheduled for a cardiopulmonary exercise test (CPET) for risk stratification. In this patient who is tolerating beta…

…anti-thrombotic agent in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). The primary safety endpoint is the incidence of post-procedural…

…diabetes patient is in the ER due to chest discomfort and dyspnea. His cardiovascular risk profile, duration of diabetes, sex, age and symptoms are all…

…patient with hypertension. ECG is recorded during his annual health screening. He is asymptomatic during the recording. Heart rate 67 beats per minute. Identify all…

…The patient was initially unresponsive but regained consciousness and was subsequently found to have had an episode of atrial fibrillation with rapid ventricular response resulting…

What percentage of all deaths from cardiovascular disease is attributed to sudden unexpected cardiac arrests?

…to the emergency department with palpitations and near-syncope. His ECG shows a wide QRS complex tachycardia at a rate of 180 bpm. All precordial…

In which specific group of athletes might T-wave inversion confined to the anterior precordial leads be considered a normal age-related pattern, often referred…